Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;54(4):2445-2457.
doi: 10.1007/s12035-016-9840-3. Epub 2016 Mar 12.

Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis

Mansoureh Togha  1 , Mehrdad Jahanshahi  2 , Leila Alizadeh  3 , Soodeh Razeghi Jahromi  3   4 , Gelareh Vakilzadeh  5 , Bahram Alipour  6 , Ali Gorji  3   7 , Amir Ghaemi  8   9
Affiliations

Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis

Mansoureh Togha et al. Mol Neurobiol. 2017 May.

Retraction in

Abstract

The immunomodulatory and anti-inflammatory properties of bone marrow-derived mesenchymal stem cells (BM-MSCs) have been considered as an appropriate candidate for treatment of autoimmune diseases. Previous studies have revealed that treatment with BM-MSCs may modulate immune responses and alleviate the symptoms in experimental autoimmune encephalomyelitis (EAE) mice, an animal model of multiple sclerosis. Therefore, the present study was designed to examine immunomodulatory effects of BM-MSCs in the treatment of myelin oligodendrocyte glycoprotein (MOG) 35-55-induced EAE in C57BL/6 mice. MSCs were obtained from the bone marrow of C57BL mice, cultured with DMEM/F12, and characterized with flow cytometry for the presence of cell surface markers for BM-MSCs. Following three passages, BM-MSCs were injected intraperitoneally into EAE mice alone or in combination with rapamycin. Immunological and histopathological effects of BM-MSCs and addition of rapamycin to BM-MSCs were evaluated. The results demonstrated that adding rapamycin to BM-MSCs transplantation in EAE mice significantly reduced inflammation infiltration and demyelination, enhanced the immunomodulatory functions, and inhibited progress of neurological impairments compared to BM-MSC transplantation and control groups. The immunological effects of rapamycin and BM-MSC treatments were associated with the inhibition of the Ag-specific lymphocyte proliferation, CD8+ cytolytic activity, and the Th1-type cytokine (gamma-interferon (IFN-γ)) and the increase of Th-2 cytokine (interleukin-4 (IL-4) and IL-10) production. Addition of rapamycin to BM-MSCs was able to ameliorate neurological deficits and provide neuroprotective effects in EAE. This suggests the potential of rapamycin and BM-MSC combined therapy to play neuroprotective roles in the treatment of neuroinflammatory disorders.

Keywords: Cytokine; Multiple sclerosis; Neuropharmacology; Neuroprotection; Stem cells.

PubMed Disclaimer

References

    1. Kidney Int. 2001 Jan;59(1):3-16 - PubMed
    1. J Neurol Sci. 2009 Feb 1;277 Suppl 1:S3-8 - PubMed
    1. Immunology. 2008 Oct;125(2):161-9 - PubMed
    1. J Neuroimmunol. 2012 Feb 29;243(1-2):43-51 - PubMed
    1. Epilepsia. 2007 Apr;48(4):834-6 - PubMed

Publication types

MeSH terms

LinkOut - more resources